CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works

Global Cancer Statistics, 2002

Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,573 · see citing works

Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets

Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855 · see citing works

MicroRNA expression profiles classify human cancers

Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,497 · see citing works

A microRNA expression signature of human solid tumors defines cancer gene targets

Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697 · see citing works

Esophageal Cancer

Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,511 · see citing works

Role of CD47 as a Marker of Self on Red Blood Cells

Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,975 · see citing works

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752 · see citing works

Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.

Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 1,751 · see citing works

LNA-mediated microRNA silencing in non-human primates

Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · see citing works

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

Tepper, J. E., Krasna, M. J., Niedzwiecki, D., Hollis, D. R., Reed, C. E., Goldberg, R. M., Kiel, K. D., Willett, C. G., Sugarbaker, D. J., & Mayer, R. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9593 · Cited by 1,352 · see citing works

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

Gebski, V., Burmeister, B. H., Smithers, B. M., Foo, K., Zalcberg, J. R., & Simes, J. R. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70039-6 · Cited by 1,158 · see citing works

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,095 · see citing works

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 795 · see citing works

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

Wong, T., Liu, X., Wong, B. Y., Ng, R. W. M., Yuen, A. P. W., & Wei, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0666 · Cited by 750 · see citing works

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Chan, K. S., Espinosa, Í., Chao, M. P., Wong, D. J., Ailles, L., Diehn, M., Gill, H. S., Presti, J. C., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 658 · see citing works

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., & Meinl, E. (2009) · Brain · doi:10.1093/brain/awp300 · Cited by 595 · see citing works

CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens

Asano, K., Nabeyama, A., Miyake, Y., Qiu, C., Kurita, A., Tomura, M., Kanagawa, O., Fujii, S., & Tanaka, M. (2010) · Immunity · doi:10.1016/j.immuni.2010.12.011 · Cited by 454 · see citing works

miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y., Chiyomaru, T., Enokida, H., Nakagawa, M., & Matsubara, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25284 · Cited by 441 · see citing works

MicroRNAs in Disease and Potential Therapeutic Applications

Soifer, H. S., Rossi, J. J., & Sætrom, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300311 · Cited by 394 · see citing works

Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Jan, M., Weissman-Tsukamoto, R., Zhao, F., Park, C. Y., Weissman, I. L., & Majeti, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2238 · Cited by 381 · see citing works

Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma

Childs, G. J., Fazzari, M. J., Kung, G., Kawachi, N., Brandwein‐Gensler, M. S., McLemore, M. S., Chen, Q., Burk, R. D., Smith, R. V., Prystowsky, M. B., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080731 · Cited by 360 · see citing works

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Guo, Y., Chen, Z., Zhang, L., Zhou, F., Shi, S., Feng, X., Li, B., Meng, X., Ma, X., Luo, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-06-4418 · Cited by 339 · see citing works

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 324 · see citing works

Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System

Okazawa, H., Motegi, S., Ohyama, N., Ohnishi, H., Tomizawa, T., Kaneko, Y., Oldenborg, P., Ishikawa, O., & Matozaki, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2004 · Cited by 303 · see citing works

Macrophages as mediators of tumor immunosurveillance

Jaiswal, S., Chao, M. P., Majeti, R., & Weissman, I. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.001 · Cited by 241 · see citing works

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis

Malthaner, R. A., Wong, R. K. S., Rumble, R. B., Zuraw, L., & Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-35 · Cited by 223 · see citing works

Prognostic Significance of Fascin Overexpression in Human Esophageal Squamous Cell Carcinoma

Hashimoto, Y., Ito, T., INOUE, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1378 · Cited by 157 · see citing works

Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells

Rao, P. K., Missiaglia, E., Shields, L. Y., Hyde, G., Yuan, B., Shepherd, C. J., SHIPLEY, J. M., & Lodish, H. F. (2010) · The FASEB Journal · doi:10.1096/fj.09-150698 · Cited by 128 · see citing works

Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma

Seki (2010) · International Journal of Oncology · doi:10.3892/ijo_00000840 · Cited by 121 · see citing works

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

Missiaglia, E., Shepherd, C. J., Patel, S. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605684 · Cited by 120 · see citing works

Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice

Oldenborg, P. (2002) · Blood · doi:10.1182/blood.v99.10.3500 · Cited by 108 · see citing works

Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47 null cells

Wang, H., Madariaga, M. L. L., Wang, S., van Rooijen, N., Oldenborg, P., & Yang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702881104 · Cited by 94 · see citing works

Differential miRNA expression profiles in bladder urothelial carcinomas.

Song, T., Xia, W., Shao, N., et al. (2010) · PubMed · Cited by 91 · see citing works

Innate immune ‘self’ recognition: a role for CD47–SIRPα interactions in hematopoietic stem cell transplantation

van den Berg, T. K., & van der Schoot, C. E. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.02.004 · Cited by 78 · see citing works

Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma.

Kuwano, H., Nakajima, M., Miyazaki, T., et al. (2003) · PubMed · Cited by 65 · see citing works

Correlated Expression ofCD47andSIRPAin Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients

Nagahara, M., Mimori, K., Kataoka, A., Ishii, H., Tanaka, F., Nakagawa, T., Sato, T., Ono, S., Sugihara, K., & Mori, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0349 · Cited by 65 · see citing works

MicroRNAs and Ischemic Heart Disease: Towards a Better Comprehension of Pathogenesis, New Diagnostic Tools and New Therapeutic Targets

Silvestri, P., Russo, C. D., Rigattieri, S., Fedele, S., Todaro, D., Ferraiuolo, G., ALTAMURA, G., & Loschiavo, P. (2009) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489009788452977 · Cited by 52 · see citing works

CD47 regulation of epithelial cell spreading and migration, and its signal transduction

Shinohara, M., Ohyama, N., Murata, Y., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00245.x · Cited by 46 · see citing works

Limited Capability of Regional Lymph Nodes to Eradicate Metastatic Cancer Cells

Nagata, H., Arai, T., Soejima, Y., Suzuki, H., Ishii, H., & Hibi∥, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1182 · Cited by 38 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Immunogenic cell death in cancer and infectious disease

Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119 · see citing works

Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer

Fucikova, J., Moserova, I., Urbanova, L., Bezu, L., Kepp, O., Cremer, I., Salek, C., Strnad, P., Kroemer, G., Galluzzi, L., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00402 · Cited by 159 · see citing works

Upregulation of COL8A1 indicates poor prognosis across human cancer types and promotes the proliferation of gastric cancer cells

Zhou, J., Song, Y., Gan, W., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11895 · Cited by 20 · see citing works

Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells

LI, H., Xie, S., LIU, X., et al. (2014) · Oncology Reports · doi:10.3892/or_xxxxxxxx · Cited by 27 · see citing works

microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells

Zhou, C., Li, X., Zhang, X., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1737 · Cited by 44 · see citing works

Downregulation of microRNA‑142‑3p and its tumor suppressor role in gastric cancer

Wang, Y., Cao, Z., Wang, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8330 · Cited by 30 · see citing works